SciELO - Scientific Electronic Library Online

 
vol.22 número1Detección de mutaciones en el dominio tirosina quinasa de BCR-ABL1 en pacientes colombianos con leucemia mieloide crónica LMC, resistentes al imatinib índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Cancerología

versión impresa ISSN 0123-9015

Resumen

PRADA, Sergio I.  y  CONTRERAS, Juan F.. Last-year-of-life expenditure of patients diagnosed with cancer. rev.colomb.cancerol. [online]. 2018, vol.22, n.1, pp.3-7. ISSN 0123-9015.  https://doi.org/10.1016/j.rccan.2018.01.002.

Objective:

To estimate last-year-of-life expenditure for patients diagnosed with cancer in Colombia.

Methods:

This is a descriptive retrospective study. Using claims data for two HMO for years 20112013, last-year-of-life expenditure was estimated for all persons dying in 2012-2013. Cancer diagnoses were identified using ICD-10 codes. Last-year-of-life expenditure was defined as allservices provided between the date of death and the 360 days previous.

Results:

A cancer diagnosis was recorded in 30.4% of the deceased and accounted for 43.6% of total last-year-of-life expenditure in 2012, and 40% in 2013. The mean per deceased expenditure was between 72% and 76% higher for patients with cancer as compared to patients without cancer. Last-year-of-life expenditure increases with the proximity to death.

Conclusion:

The use of resources for people dying with cancer diagnosis could be reduced with palliative care programs that give patients a quality of life.

Palabras clave : Health services; Terminal care; Death.

        · resumen en Español     · texto en Español     · Español ( pdf )